Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial.

@article{Greenspan2003CombinationTW,
  title={Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial.},
  author={Susan L. Greenspan and Neil M. Resnick and Robert A. Parker},
  journal={JAMA},
  year={2003},
  volume={289 19},
  pages={2525-33}
}
CONTEXT Therapy with individual antiresorptive agents has been shown to be effective for prevention and treatment of postmenopausal osteoporosis, but whether combination antiresorptive therapy with hormones and bisphosphonates is safe or efficacious or how these agents compare in elderly women is unknown. OBJECTIVE To determine whether hormone replacement and the bisphosphonate alendronate sodium in combination are efficacious and safe, and how they compare with monotherapy in community… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 30 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 35 references

HORMONE REPLACEMENT AND ALENDRONATE THERAPY FOR PREVENTION OF BONE LOSS 2532 JAMA, May 21, 2003—Vol

SL Greenspan, LA Maitland, ER Myers, Krasnow
J Bone Miner Res • 2003

Similar Papers

Loading similar papers…